Jubilant Pharmova Limited has informed the Exchange regarding Change in Director(s) of the company.
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Arvind Chokhany, the Group Chief Financial Officer and Whole-time Director of Jubilant Pharmova Limited, has resigned from the company to take up an external opportunity. He submitted his resignation letter on July 29, 2025, and will formally step down from his roles at the close of business on September 30, 2025. This gives the company about two months to arrange a transition and find a replacement for the CFO position. The announcement is a standard disclosure under SEBI's Listing Regulations.
The departure of the CFO is a key management change that could create short-term uncertainty around financial leadership and continuity. Investors will watch closely for news of a successor, as a smooth transition is important to maintain investor confidence.